NCT06377527Recruiting

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

M.D. Anderson Cancer Center

Start Date

7/10/2024

Completion Date

12/28/2037

Summary

To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.

Detailed Description

Primary Objectives 1\. To collect data on participants characteristics, disease characterization, pathology and molecular data, treatment, and outcomes for participants with gynecologic mesonephric-like adenocarcinoma (MLA). Secondary Objectives 1. To organize clinical information to support multifaceted queries of participant characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with participant outcome. 2. To have a single data repository kept on a secure platform that will integrate clinical information and research findings and serve as an archive for future research.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Adult patients over the age of 18. 2. Patients with a diagnosis of gynecologic mesonephric-like adenocarcinoma (MLA), mesonephric adenocarcinoma (MA), mesonephric carcinosarcoma, or mesonephric-like carcinosarcomas. 3. For patients who provide consent, they must speak and/or read English or Spanish. Exclusion Criteria: 1. Patients with other subtypes of EACs. 2. Patients who are considered cognitively impaired. Assessment will be obtained based on their need of a Legally Authorized Representative.

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Mesonephric-like Adenocarcinoma

Locations

MD Anderson Cancer Center

Houston, Texas 77030

United States